ATE268322T1 - Inhibitoren der tryptase - Google Patents
Inhibitoren der tryptaseInfo
- Publication number
- ATE268322T1 ATE268322T1 AT00990777T AT00990777T ATE268322T1 AT E268322 T1 ATE268322 T1 AT E268322T1 AT 00990777 T AT00990777 T AT 00990777T AT 00990777 T AT00990777 T AT 00990777T AT E268322 T1 ATE268322 T1 AT E268322T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- tryptase
- meanings
- compounds
- indicated
- Prior art date
Links
- 102000001400 Tryptase Human genes 0.000 title 1
- 108060005989 Tryptase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002750 tryptase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99125382 | 1999-12-20 | ||
| PCT/EP2000/012840 WO2001046128A2 (en) | 1999-12-20 | 2000-12-16 | Tryptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE268322T1 true ATE268322T1 (de) | 2004-06-15 |
Family
ID=8239660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00990777T ATE268322T1 (de) | 1999-12-20 | 2000-12-16 | Inhibitoren der tryptase |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6815557B2 (de) |
| EP (1) | EP1244614B1 (de) |
| JP (1) | JP2003518087A (de) |
| AT (1) | ATE268322T1 (de) |
| AU (1) | AU783371B2 (de) |
| CA (1) | CA2392127A1 (de) |
| DE (1) | DE60011300T2 (de) |
| DK (1) | DK1244614T3 (de) |
| ES (1) | ES2222270T3 (de) |
| PT (1) | PT1244614E (de) |
| SI (1) | SI1244614T1 (de) |
| TR (1) | TR200402164T4 (de) |
| WO (1) | WO2001046128A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1358182E (pt) | 2001-01-31 | 2004-12-31 | Altana Pharma Ag | Derivados de diazocinas e sua utilizacao como inibidores de triptase |
| CA2438711A1 (en) | 2001-02-21 | 2002-08-29 | Altana Pharma Ag | Tryptase inhibitors |
| JP2004518736A (ja) | 2001-02-21 | 2004-06-24 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
| WO2002074732A2 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| JP2004525926A (ja) * | 2001-03-15 | 2004-08-26 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼ阻害剤 |
| ES2278928T3 (es) | 2001-06-19 | 2007-08-16 | Altana Pharma Ag | Inhibidores de triptasa. |
| GB0507577D0 (en) * | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3999946A (en) * | 1976-02-23 | 1976-12-28 | Allied Chemical Corporation | Time-temperature history indicators |
| US4228126A (en) * | 1977-11-25 | 1980-10-14 | Allied Chemical Corporation | Diacetylene time-temperature indicators |
| WO1995032945A1 (en) * | 1994-06-01 | 1995-12-07 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell mediated conditions |
| KR970706267A (ko) | 1994-09-23 | 1997-11-03 | 다니엘 에이치. 페트리 | 비만 세포 염증성 질환 치료용 조성물 및 방법(compositions and methods for treating mast-cell inflammatory condition) |
| AU733621B2 (en) | 1996-07-30 | 2001-05-17 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions for treating diseases associated with tryptase activity |
| AU8997498A (en) | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| US6221914B1 (en) * | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| EP1030844A1 (de) | 1997-11-10 | 2000-08-30 | Array Biopharma Inc. | Verbindungen, die die aktivität von tryptase hemmen |
| ES2233025T3 (es) | 1998-02-06 | 2005-06-01 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Agente inhibidores de la triptasa. |
| EP1060171A2 (de) * | 1998-02-06 | 2000-12-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
| WO2000014097A2 (de) | 1998-09-04 | 2000-03-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue pyranosen |
| JP2003506442A (ja) | 1999-08-10 | 2003-02-18 | アルタナ ファルマ アクチエンゲゼルシャフト | 新規トリプターゼインヒビター |
| JP2003509417A (ja) | 1999-09-14 | 2003-03-11 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
-
2000
- 2000-12-16 JP JP2001547039A patent/JP2003518087A/ja not_active Withdrawn
- 2000-12-16 SI SI200030463T patent/SI1244614T1/xx unknown
- 2000-12-16 ES ES00990777T patent/ES2222270T3/es not_active Expired - Lifetime
- 2000-12-16 PT PT00990777T patent/PT1244614E/pt unknown
- 2000-12-16 US US10/149,517 patent/US6815557B2/en not_active Expired - Fee Related
- 2000-12-16 AT AT00990777T patent/ATE268322T1/de not_active IP Right Cessation
- 2000-12-16 CA CA002392127A patent/CA2392127A1/en not_active Abandoned
- 2000-12-16 AU AU30131/01A patent/AU783371B2/en not_active Ceased
- 2000-12-16 WO PCT/EP2000/012840 patent/WO2001046128A2/en not_active Ceased
- 2000-12-16 DE DE60011300T patent/DE60011300T2/de not_active Expired - Fee Related
- 2000-12-16 DK DK00990777T patent/DK1244614T3/da active
- 2000-12-16 TR TR2004/02164T patent/TR200402164T4/xx unknown
- 2000-12-16 EP EP00990777A patent/EP1244614B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1244614A2 (de) | 2002-10-02 |
| US20030073720A1 (en) | 2003-04-17 |
| DE60011300D1 (de) | 2004-07-08 |
| JP2003518087A (ja) | 2003-06-03 |
| AU3013101A (en) | 2001-07-03 |
| WO2001046128A3 (en) | 2001-11-22 |
| SI1244614T1 (en) | 2004-10-31 |
| DE60011300T2 (de) | 2005-08-04 |
| AU783371B2 (en) | 2005-10-20 |
| CA2392127A1 (en) | 2001-06-28 |
| US6815557B2 (en) | 2004-11-09 |
| ES2222270T3 (es) | 2005-02-01 |
| WO2001046128A2 (en) | 2001-06-28 |
| DK1244614T3 (da) | 2004-09-27 |
| TR200402164T4 (tr) | 2004-10-21 |
| PT1244614E (pt) | 2004-10-29 |
| EP1244614B1 (de) | 2004-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2186874T3 (es) | Analogos de m-amidinofenilo como inhibidores del factor xa. | |
| DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
| PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
| UA91002C2 (ru) | 7-фенилалкилзамещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поле(адф-рибоза)полимеразы | |
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| BR0007922A (pt) | Compostos calcilìticos | |
| SE9903290D0 (sv) | Novel compounds | |
| ATE287403T1 (de) | 6-phenylbenzonaphthyidine | |
| ATE269313T1 (de) | Tryptase-inhibitoren | |
| DK1204659T3 (da) | Serotonerge benzofuraner | |
| DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
| BRPI0415285A (pt) | derivados de aminoalcanol | |
| DE60011300D1 (de) | Inhibitoren der tryptase | |
| ATE348803T1 (de) | Tryptase-inhibitoren | |
| ATE364037T1 (de) | Tryptasehemmer | |
| ATE491709T1 (de) | Pyrrolidinohydrochinazoline | |
| AU758194C (en) | Novel benzimidazoles and benzoxazoles | |
| DE60120398D1 (de) | Imidazopyridin-8-one | |
| DK1358182T3 (da) | Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer | |
| ATE349427T1 (de) | Tryptaseinhibitoren | |
| SG145571A1 (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1244614 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |